START PROGRAM: STATE-OF-THE-ART ONCOLOGY IN EUROPE www.startoncology.net RARECARENet kick-off Luxembourg – July 13, 2012 Chairperson: Dr. Lisa Licitra.

Slides:



Advertisements
Similar presentations
High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Advertisements

PET/CT in Oncology George Segall, M.D. Stanford University.
National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Ref: Maxillofacial Imaging ,T A Larheim , P L Westesson 2006
9 Chapter Nine Neoplasms. © 2013 The McGraw-Hill Companies, Inc. All rights reserved. Learning Outcomes After completing this chapter, you will be able.
Section 7 Nomenclature and classification. All tumors (benign and malignant) have two basic components. Proliferating neoplastic cells that constitute.
Brain Tumors Maria Rountree. Most common types of brain tumors The most common childhood tumors are: The most common childhood tumors are: 1. Astrocytoma.
Pediatric Neurosurgical Neuropathology
Brain tumors = leading cause of solid tumor deaths in children Low grade brain tumors = most common NO CURES CURRENT TREATMENT = TOXIC Better treatments.
Challenges and Considerations in Linking Adult and Pediatric CNS Malignancies Henry S. Friedman, MD The Brain Tumor Center at Duke.
Hematopoietic and Lymphoid Neoplasm Project. Background Peggy Adamo, RHIT, CTR NCI SEER September 2009.
AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.
Childhood leukaemia in Great Britain: trends in incidence, survival and ‘cure’ Anjali Shah UK Association of Cancer Registries conference 30 September.
Nursing Care of the Child With Cancer. Neoplasia Cell growth in cancerous tissue proliferates in disorderly and chaotic ways Neoplasm- literally “new.
Intra-Axial Tumors: Gliomas: One of the most common types of primary brain tumors arising from the brain tissue itself, gliomas arise from the supporting.
Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6 3rd meeting National Institute of Public Health Warsaw 25th.
Tumors of the CNS can be: Primary Secondary
CNS Neoplasm Dr. Raid Jastania, FRCPC Assistant Professor, Faculty of Medicine, Umm Alqura University Vice Dean, Faculty of Dentistry.
Setting the scene Louise Soanes TCT Nurse Consultant for AYA The Royal Marsden NHS Foundation Trust.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
TRANSFORMING THE CHILDHOOD CANCER SURVIVOR EXPERIENCE Additional Material.
Case for Support. Blood Cancers More than 1 million North Americans are fighting blood cancers, the third leading cause of cancer deaths. Early detection.
Incidence of Childhood Cancer. What is cancer ? Uncontrolled growth of cells Are these cancer cells abnormal? No, but their behaviour is.
What is LDN? It is a lower dosage of the FDA-approved drug, naltrexone which is used to treat heroin and opium addiction by blocking the body’s opioid.
Nico van Zandwijk Head of the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Former secretary and chairman of.
Information network on rare cancers INFORMATION NETWORK ON RARE CANCERS (RARECARENet) Kick-off meeting - Friday, July Gemma Gatta Fondazione IRCCS,
1 Cancer Etiology Dan Aderka MD Molecular mechanisms Environment Cancer cells.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Tumors  Gliomas  Neuronal tumors  Poorly differentiated neoplasms  Other parenchymal tumors  Meningiomas  Paraneoplastic syndromes  Peripheral.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
13 site specific articles 13 site specific articles Adult patients (age 15+) Adult patients (age 15+) Survival by subsite, tumour morphology, stage Survival.
EEOICPA Compensation Results (through March 2004) Russ Henshaw, MS Epidemiologist NIOSH/Office of Compensation Analysis & Support Cincinnati, OH.
INTRODUCTION TO PEDIATRIC ONCOLOGY Prof.Dr.Reha Cengizlier
Terms in Oncology & Its Causes
Brain:Spinal cord tumors 10:1
NECK MASSES.
In humans, billions of cells die each day Cells die in two ways: 1.Necrosis 2.Apoptosis.
CONGENITAL NEVI. Common Malignant Neoplasms of Infancy and ChildhoodCommon Malignant Neoplasms of Infancy and Childhood 0 to 4 Years5 to 9 Years10 to.
I’m not just a child. I’m a daughter. I’m a son. I’m also a friend, a parent, a wife, a husband…
Neoplasia Lecture 1 Abdulmalik Alsheikh, M.D, FRCPC Dr. Maha Arafah, MBBS, KSFP Foundation block 2013 Pathology Foundation block 2013 Pathology Definition.
Brain Tumors Mark Browning, M.D. IUSME. Differential Diagnosis includes: Primary CNS tumor Most common primary sites of brain mets: – Lung – Breast.
In describing a person’s cancer what would T2 mean? In describing a person’s cancer what does M1 mean? In describing a person’s cancer what does N0 mean?
Cancer52 Infrastructure Board of directors Simon Davies, Chair Lindsey Bennister Kathy Oliver Honorary President Baroness Delyth Morgan of Drefelin Strategy.
Introduction to the NHLBI Context. Agenda  Introduction to the NMDP / CIBMTR  Forms being curated  Progress update  Description of review process.
RARECARE project Proposal for improving data quality on rare cancers with high priority Granada, March 25 th 2009 Andalusian School of Public Health.
WHAT ARE CLINICAL PRACTICE GUIDELINES?
A 58 year-old man with bilateral lung transplant three years ago for severe COPD presents with pleural effusion and pleural-based lung nodules. A whole.
Cancer Facts MS JYOTI SHAH CONSULTANT UROLOGICAL SURGEON SOURCE: CANCER RESEARCH UK.
Brain Tumours – what should I know?
Cancer Waiting Times, UK countries   England Wales Scotland
Neurological Neoplasm FOM, KFMC
Systemic Anti Cancer Therapy (SACT) Cancer 52 Ralphael Oghagbon
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
NECK MASSES.
Glioblastoma Multiforme SSEA1+ CD133+
REGIONAL METASTATIC DISEASE OF THE NECK NECK DISSECTION
Pediatric Neurosurgical Neuropathology
Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual
Incidence of nonskin cancers at five years
Childhood Cancer Statistics, England, Annual report 2018.
What’s New for 8th Edition
Hotspot mutations drive clustering of tumor types
WES detects a limited number of clinically targetable alterations in patients with advanced cancer. WES detects a limited number of clinically targetable.
Sinonasal Tumours Otolaryngology Rhinology
IMITAB® (Imatinib Mesylate BP Tablets)
Minimal Residual Disease and Hematologic Malignancies
TRENDS OF CANCER OBSERVED IN A PREMIER INSTITUTE IN MUMBAI, INDIA DURING LAST THREE DECADES Dr. Ganesh B. Prof. & Head, Department of Medical Records,
Fig. 3. Survival rates according to histologic diagnosis
Presentation transcript:

START PROGRAM: STATE-OF-THE-ART ONCOLOGY IN EUROPE RARECARENet kick-off Luxembourg – July 13, 2012 Chairperson: Dr. Lisa Licitra Fond. IRCCS Istituto Tumori Milano

Information network on rare cancers PROFESSIONAL AREA (FOR CANCER SPECIALISTS) - One chapter on each existing neoplasm (in English) - One chapter on each existing neoplasm (in Italian) PUBLIC AREA (FOR NON SPECIALISTS) - Information sections in Italian on: a) single neoplasms b) cancer-related issues (general information on cancer, antiemetic therapy, …) ) THE START WEBSITE (

Information network on rare cancers MEAN OF ACCESSES TO START WEBSITE JANUARY – JUNE ( hits)

Information network on rare cancers Standard ("standard", "recommended" [or "not recommended") - This can be considered a conventional choice for the average patient. Individualized  suitable for individual clinical use  investigational or suitable for individual clinical use - This is not a standard option, but it can be a reasonable choice for the individual patient. The patient should be informed that the option is not standard and the decision must be shared with the patient. Investigational only - This is something which, in principle, can be offered to the patient only within a clinical study. CLINICAL RECOMMENDATIONS TYPE OF OPTION

Information network on rare cancers OBJECTIVE – WP 4-5 Developing at least 10 chapters on selected rare cancers (5 new ones and updating 5 existing ones). Providing the laymen's version. Developing a database on very rare cancer with access restricted to physicians only.

Information network on rare cancers ACTIONS ALREADY UNDERTAKEN SELECTED 5 NEW START CHAPTERS - Thymus - Oral cavity - Nasal cavity - Head and neck mucosal melanoma - Small intestine SELECTED 5 START CHAPTERS TO BE UPDATED - Chronic Lymphocytic Leukemia - Cholangiocarcinoma - Gastrointestinal Stromal Tumours (GISTs) - Hepatocellular carcinoma - Langerhans cell histiocytosis

Information network on rare cancers Rare Tumors I Adult acute lymphoblastic leukaemia (ALL) Adult acute myeloid leukaemia (AML) Kaposi's sarcoma Non-Hodgkin's lymphoma Adult neuroectodermal tumours of posterior fossa (Medulloblastoma) and of supratentorial sites Anaplastic astrocytoma in adults Ependymoma Glioblastoma multiforme Low-grade astrocytoma Meningioma Oligodendroglioma Adult neuroectodermal tumours of posterior fossa (Medulloblastoma) and of supratentorial sites Anaplastic astrocytoma in adults Ependymoma Glioblastoma multiforme Low-grade astrocytoma Meningioma Oligodendroglioma Cancer of the pancreas Chronic Lymphocytic Leukemia Cancer of the anal region

Information network on rare cancers Rare Tumors II Cholangiocarcinoma Cancer of the penis Germ-cell tumours of the testis Cancer of the endometrium Ovarian cancer Cancer of nasopharynx Cancer of the larynx Cancer of the oropharynx Major and minor salivary gland tumours Thyroid cancer Hemophagocytic lymphohistiocytosis Histiocyte Disorders Langerhans cell histiocytosis Rosai-Dorfman disease Hepatocellular carcinoma Childhood Medulloblastoma Multiple myeloma Neuroblastoma Ewing's sarcoma Gastrointestinal Stromal Tumours (GISTs) Soft tissue sarcomas Wilm’s Tumour